American Banking and Market News logo

The Latest Headlines at American Banking and Market News

Image about DHI Media (TSE:WIL) Downgraded by Canaccord Genuity Group to “Hold”

DHI Media (TSE:WIL) Downgraded by Canaccord Genuity Group to “Hold”

Canaccord Genuity Group downgraded shares of DHI Media (TSE:WIL – Free Report) from a moderate buy rating to a hold rating in a research note issued to investors on Monday morning, Zacks.com reports. DHI Media Stock Performance Read... More of this article »
Image about Q2 2024 EPS Estimates for Oncternal Therapeutics, Inc. (NASDAQ:ONCT) Increased by HC Wainwright

Q2 2024 EPS Estimates for Oncternal Therapeutics, Inc. (NASDAQ:ONCT) Increased by HC Wainwright

Oncternal Therapeutics, Inc. (NASDAQ:ONCT – Free Report) – Analysts at HC Wainwright increased their Q2 2024 EPS estimates for shares of Oncternal Therapeutics in a report issued on Monday, May 13th. HC Wainwright analyst... More of this article »
Image about Northland Capmk Equities Analysts Decrease Earnings Estimates for PHX Minerals Inc. (NYSE:PHX)

Northland Capmk Equities Analysts Decrease Earnings Estimates for PHX Minerals Inc. (NYSE:PHX)

PHX Minerals Inc. (NYSE:PHX – Free Report) – Analysts at Northland Capmk dropped their Q2 2024 earnings per share (EPS) estimates for shares of PHX Minerals in a research note issued to investors on Tuesday, May 14th.... More of this article »
Image about Polar Capital Holdings plc (LON:POLR) Insider Gavin Rochussen Acquires 18,359 Shares

Polar Capital Holdings plc (LON:POLR) Insider Gavin Rochussen Acquires 18,359 Shares

Polar Capital Holdings plc (LON:POLR – Get Free Report) insider Gavin Rochussen purchased 18,359 shares of the company’s stock in a transaction on Tuesday, May 14th. The stock was acquired at an average price of GBX 550... More of this article »
Image about Q2 2024 EPS Estimates for FiscalNote Holdings, Inc. Lifted by Analyst (NYSE:NOTE)

Q2 2024 EPS Estimates for FiscalNote Holdings, Inc. Lifted by Analyst (NYSE:NOTE)

FiscalNote Holdings, Inc. (NYSE:NOTE – Free Report) – Northland Capmk raised their Q2 2024 earnings per share estimates for FiscalNote in a note issued to investors on Monday, May 13th. Northland Capmk analyst M. Latimore... More of this article »
Image about Equities Analysts Set Expectations for Pembina Pipeline Co.’s Q2 2024 Earnings (NYSE:PBA)

Equities Analysts Set Expectations for Pembina Pipeline Co.’s Q2 2024 Earnings (NYSE:PBA)

Pembina Pipeline Co. (NYSE:PBA – Free Report) (TSE:PPL) – Stock analysts at Atb Cap Markets reduced their Q2 2024 earnings per share estimates for shares of Pembina Pipeline in a report issued on Sunday, May 12th. Atb... More of this article »
Image about Q2 2024 EPS Estimates for Ormat Technologies, Inc. (NYSE:ORA) Lifted by Analyst

Q2 2024 EPS Estimates for Ormat Technologies, Inc. (NYSE:ORA) Lifted by Analyst

Ormat Technologies, Inc. (NYSE:ORA – Free Report) – Analysts at Roth Capital increased their Q2 2024 earnings estimates for Ormat Technologies in a report issued on Monday, May 13th. Roth Capital analyst J. Clare now... More of this article »
Image about PACCAR Inc Forecasted to Post Q2 2024 Earnings of $2.12 Per Share (NASDAQ:PCAR)

PACCAR Inc Forecasted to Post Q2 2024 Earnings of $2.12 Per Share (NASDAQ:PCAR)

PACCAR Inc (NASDAQ:PCAR – Free Report) – Investment analysts at Zacks Research raised their Q2 2024 earnings per share estimates for shares of PACCAR in a research report issued to clients and investors on Tuesday,... More of this article »
Image about Q2 2024 EPS Estimates for Oculis Holding AG (NASDAQ:OCS) Cut by Analyst

Q2 2024 EPS Estimates for Oculis Holding AG (NASDAQ:OCS) Cut by Analyst

Oculis Holding AG (NASDAQ:OCS – Free Report) – Research analysts at HC Wainwright decreased their Q2 2024 earnings estimates for Oculis in a research report issued on Monday, May 13th. HC Wainwright analyst Y. Chen... More of this article »
Image about Q2 2024 EPS Estimates for Processa Pharmaceuticals, Inc. Cut by Analyst (NASDAQ:PCSA)

Q2 2024 EPS Estimates for Processa Pharmaceuticals, Inc. Cut by Analyst (NASDAQ:PCSA)

Processa Pharmaceuticals, Inc. (NASDAQ:PCSA – Free Report) – Investment analysts at HC Wainwright dropped their Q2 2024 EPS estimates for Processa Pharmaceuticals in a research note issued to investors on Monday, May... More of this article »
Image about Brokers Issue Forecasts for Prosperity Bancshares, Inc.’s Q2 2024 Earnings (NYSE:PB)

Brokers Issue Forecasts for Prosperity Bancshares, Inc.’s Q2 2024 Earnings (NYSE:PB)

Prosperity Bancshares, Inc. (NYSE:PB – Free Report) – Analysts at Zacks Research lifted their Q2 2024 earnings per share (EPS) estimates for Prosperity Bancshares in a research note issued to investors on Tuesday, May... More of this article »
Image about HC Wainwright Analysts Cut Earnings Estimates for MacroGenics, Inc. (NASDAQ:MGNX)

HC Wainwright Analysts Cut Earnings Estimates for MacroGenics, Inc. (NASDAQ:MGNX)

MacroGenics, Inc. (NASDAQ:MGNX – Free Report) – Investment analysts at HC Wainwright reduced their Q2 2024 EPS estimates for shares of MacroGenics in a research report issued to clients and investors on Monday, May... More of this article »
Image about Equities Analysts Issue Forecasts for Phio Pharmaceuticals Corp.’s Q2 2024 Earnings (NASDAQ:PHIO)

Equities Analysts Issue Forecasts for Phio Pharmaceuticals Corp.’s Q2 2024 Earnings (NASDAQ:PHIO)

Phio Pharmaceuticals Corp. (NASDAQ:PHIO – Free Report) – Analysts at HC Wainwright issued their Q2 2024 earnings per share (EPS) estimates for shares of Phio Pharmaceuticals in a research note issued to investors on... More of this article »
Image about Q2 2024 Earnings Estimate for McDonald’s Co. (NYSE:MCD) Issued By Zacks Research

Q2 2024 Earnings Estimate for McDonald’s Co. (NYSE:MCD) Issued By Zacks Research

McDonald’s Co. (NYSE:MCD – Free Report) – Investment analysts at Zacks Research decreased their Q2 2024 earnings estimates for shares of McDonald’s in a report issued on Tuesday, May 14th. Zacks Research... More of this article »
Image about Roth Capital Analysts Lift Earnings Estimates for Moleculin Biotech, Inc. (NASDAQ:MBRX)

Roth Capital Analysts Lift Earnings Estimates for Moleculin Biotech, Inc. (NASDAQ:MBRX)

Moleculin Biotech, Inc. (NASDAQ:MBRX – Free Report) – Equities researchers at Roth Capital upped their Q2 2024 earnings per share estimates for shares of Moleculin Biotech in a research note issued to investors on Monday,... More of this article »